|
|
|
| Effect of Tislelizumab Combined with TP Chemotherapy Regimen in the Treatment of Stage ⅢB to Ⅳ Non-small Cell Lung Cancer and Its Influence on Serum PI3K, Akt Levels |
| PENG Wenjian, LI Guanyin, XU Ge |
| First-author's address: Department of Oncology Center 2, the Second Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China |
|
|
